Author(s):
Surender Jangra, Paramjeet Singh Gill, Deepinder Singh, Suman Sharma, Savita Bhatia, Khushwant Nandal
Email(s):
sjndri@gmail.com
DOI:
10.52711/0974-360X.2023.00235 
Address:
Surender Jangra1*, Paramjeet Singh Gill2, Deepinder Singh3, Suman Sharma2, Savita Bhatia2, Khushwant Nandal2
1Department of Chemistry and Biochemistry, Sharda School of Basic Sciences and Research, Sharda University, Greater Noida, India.
2Virus Research and Diagnostic Laboratory, Department of Microbiology, Pt. B.D. Sharma University of Health Sciences, Rohtak, Haryana, India.
3Department of Microbiology, Kalpana Chawla Government Medical College, Karnal, Haryana, 132001.
*Corresponding Author
Published In:
Volume - 16,
Issue - 3,
Year - 2023
ABSTRACT:
Coronavirus disease 2019 (COVID19) is the recently reported disease caused by novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID19 spreads among population through the close/direct contact and nasal droplets when an infected person sneezes, coughs, talks or breaths. On an average, COVID19 infected patient develops clinical symptoms 5-6 days after the infection and some develops symptoms even after 14 days of infection. Detailed study on the symptoms shown by COVID19 patients can help in identifying individuals so that proper identification and isolation of patients can be done and transmission of virus can be reduced significantly. In this study, a total of 99 (66 males and 33 female) COVID19 infected symptomatic patients without any comorbidities were included. Nasopharyngeal and oropharyngeal swabs were used for the collection of samples from the suspected patients to extract total RNA and perform real time PCR for the detection of genetic material for SARS-CoV-2. Samples with Ct value = 36 in case of Orf1ab gene and E gene with good sigmoidal curve were reported as positive for novel SARS-CoV-2. Fever, shortness of breath, dry cough and cough with sputum production persisted for longer timer and were more common symptoms reported by the COVID19 infected patients. In conclusion, understanding of the clinical symptoms shown by COVID19 infected patients can help in identification and isolation of patients so that transmission of virus can be reduced significantly.
Cite this article:
Surender Jangra, Paramjeet Singh Gill, Deepinder Singh, Suman Sharma, Savita Bhatia, Khushwant Nandal. Persistence and Prevalence of Clinical Symptoms in SARS-CoV-2 infected patients. Research Journal of Pharmacy and Technology 2023; 16(3):1428-2. doi: 10.52711/0974-360X.2023.00235
Cite(Electronic):
Surender Jangra, Paramjeet Singh Gill, Deepinder Singh, Suman Sharma, Savita Bhatia, Khushwant Nandal. Persistence and Prevalence of Clinical Symptoms in SARS-CoV-2 infected patients. Research Journal of Pharmacy and Technology 2023; 16(3):1428-2. doi: 10.52711/0974-360X.2023.00235 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2023-16-3-71
REFERENCES:
1. Salah HA. Aufi IM. Fadhil HY. Alhamdani FG. Human coronavirus species and their correlation as co-infection detected by fast real-time RT-PCR. Research journal of pharmacy and technology, 2020; 13(6): 2578-2584. doi.org/10.5958/0974-360X.2020.00459.X
2. Lim YX. Ng YL. Tam JP. Liu DX. Human coronaviruses: a review of virus–host interactions. Diseases, 2016; 4(3): 26. doi.org/10.3390/diseases4030026
3. Krishnamoorthy S. Swain B. Verma RS. Gunthe SS. SARS-CoV, MERS-CoV, and 2019-nCoV viruses: an overview of origin, evolution, and genetic variations. Virus disease, 2020; 31(4): 411-423. doi.org/10.1007/s13337-020-00632-9
4. Mesel-Lemoine M. Millet J. Vidalain PO. Law H. Vabret A. Lorin V. Escriou N. Albert ML. Nal B. Tangy F. A human coronavirus responsible for the common cold massively kills dendritic cells but not monocytes. Journal of virology, 2012; 86(14): 7577-7587. doi.org/10.1128/JVI.00269-12
5. Shereen MA. Khan S. Kazmi A. Bashir N. Siddique R. COVID19 infection: origin, transmission, and characteristics of human coronaviruses. Journal of advanced research, 2020; 24: 91-98. doi.org/10.1016/j.jare.2020.03.005
6. Martellucci CA. Flacco ME. Cappadona R. Bravi F. Mantovani L. Manzoli L. SARS-CoV-2 pandemic: an overview. Advances in biological regulation, 2020; 77: 100736. doi.org/10.1016/ j.jbior.2020.100736
7. Harapan H. Itoh N. Yufika A. Winardi W. Keam S. Te H. Megawati D. Hayati Z. Wagner AL. Mudatsir M. Coronavirus disease 2019 (COVID19): a literature review. Journal of infection and public health, 2020; 13(5): 667–673. doi.org/10.1016/ j.jiph.2020.03.019
8. Huang C. Wang Y. Li X. Ren L. Zhao J. Hu Y et al Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 2020; 395(10223): 497-506. doi.org/ 10.1016/S0140-6736(20)30183-5
9. Lu R. Zhao X. Li J. Niu P. Yang B. Wu H. Wang W. Song H. Huang B. Zhu N. Bi Y. Ma X. Zhan F. Wang L. Hu T. Zhou H et al Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet, 2020; 395(10224): 565-574. doi.org 10.1016/S0140-6736(20)30251-8
10. Zhou P. Yang XL. Wang XG. Hu B. Zhang L. Zhang W. Si HR. Zhu Y. Li B. Huang CL. Chen HD et al A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, 2020; 579: 270-273. doi.org/10.1038/s41586-020-2012-7
11. Toyoshima Y. Nemoto K. Matsumoto S. Nakamura Y. Kiyotani K. SARS-CoV-2 genomic variations associated with mortality rate of COVID19. Journal of human genetics, 2020; 65: 1075-1082. doi.org/10.1038/s10038-020-0808-9
12. Jayaweera M. Perera H. Gunawardana B. Manatunge J. Transmission of COVID19 virus by droplets and aerosols: a critical review on the unresolved dichotomy. Environmental research, 2020; 188: 109819. doi.org/10.1016/ j.envres.2020.109819
13. Ningthoujam R. COVID 19 can spread through breathing, talking, study estimates. Current medicine research and practice, 2020; 10(3): 132–133. doi.org/10.1016/j.cmrp.2020.05.003
14. Mor S. Saini P. Wangnoo SK. Bawa T. Worldwide spread of COVID-19 pandemic and risk factors among co-morbid conditions especially diabetes mellitus in India. Research journal of pharmacy and technology, 2020; 13(5): 2530-2532. doi.org/ 10.5958/0974-360X.2020.00450.3
15. Pinki. Rani D. Bajaj H. Singh R. SARS-COV-2 (COVID-19) and role of real time reverse transcription polymerase chain reaction (RT-PCR) in its diagnosis. Research journal of pharmacy and technology, 2021; 14(6): 3437-3440. doi.org/10.52711/0974-360X.2021.00598
16. Ejaz H. Alsrhani A. Zafar A. Javed H. Junaid K. Abdalla AE. Abosalif KOA. Ahmed Z. Younas S. COVID19 and comorbidities: deleterious impact on infected patients. Journal of infection and public health, 2020; 13(12): 1833-1839. doi.org/ 10.1016/j.jiph.2020.07.014
17. Li Y. Shi J. Xia J. Duan J. Chen L. Yu X. Lan W. Ma Q. Wu X. Yuan Y. Gong L. Yang X. Gao H. Wu C. Asymptomatic and symptomatic patients with non-severe coronavirus disease (COVID19) have similar clinical features and virological courses: a retrospective single center study. Frontiers in microbiology, 2020; 11: 1570. doi.org/10.3389/fmicb.2020.01570
18. Lauer SA. Grantz KH. Bi Q. Jones FK. Zheng Q. Meredith HR. Azman AS. Reich NG. Lessler J. The incubation period of coronavirus disease 2019 (COVID19) from publicly reported confirmed cases: estimation and application. Annals of internal medicine, 2020; 172(9): 577–582. doi.org/10.7326/M20-0504
19. Kim GU. Kim MJ. Ra SH. Lee J. Bae S. Jung J. Kim SH. Clinical characteristics of asymptomatic and symptomatic patients with mild COVID19. Clinical microbiology and infection, 2020; 26(7): 948.e1-948.e3. doi.org/10.1016/j.cmi.2020.04.040
20. Grant MC. Geoghegan L. Arbyn M. Mohammed Z. McGuinness L. Clarke EL. Wade RG. The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID19): a systematic review and meta-analysis of 148 studies from 9 countries. PloS One, 2020; 15(6): e0234765. doi.org/ 10.1371/journal.pone.0234765
21. Krishnasamy N. Natarajan M. Ramachandran A. Vivian Thangaraj JW. Etherajan T. Rengarajan J et al Clinical outcomes among asymptomatic or mildly symptomatic COVID19 patients in an isolation facility in Chennai, India. American journal of tropical medicine and hygiene, 2021; 104(1): 85-90. doi.org/ 10.4269/ajtmh.20-1096
22. Kim D. Quinn J. Pinsky B. Shah NH. Brown I. Rates of co-infection between SARS-CoV-2 and other respiratory pathogens. JAMA, 2020; 323(20): 2085-2086. doi.org/10.1001/ jama.2020.6266